Ascentage Pharma Group Stock Performance

ASPHF Stock  USD 8.48  0.00  0.00%   
The firm shows a Beta (market volatility) of 0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Ascentage Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ascentage Pharma is expected to be smaller as well. At this point, Ascentage Pharma has a negative expected return of -0.12%. Please make sure to confirm Ascentage Pharma's standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if Ascentage Pharma performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Ascentage Pharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
Begin Period Cash FlowB
Total Cashflows From Investing Activities-466.5 M
  

Ascentage Pharma Relative Risk vs. Return Landscape

If you would invest  932.00  in Ascentage Pharma Group on November 11, 2025 and sell it today you would lose (84.00) from holding Ascentage Pharma Group or give up 9.01% of portfolio value over 90 days. Ascentage Pharma Group is currently producing negative expected returns and takes up 2.469% volatility of returns over 90 trading days. Put another way, 22% of traded pink sheets are less volatile than Ascentage, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Ascentage Pharma is expected to under-perform the market. In addition to that, the company is 3.06 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of volatility.

Ascentage Pharma Target Price Odds to finish over Current Price

The tendency of Ascentage Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 8.48 90 days 8.48 
about 64.74
Based on a normal probability distribution, the odds of Ascentage Pharma to move above the current price in 90 days from now is about 64.74 (This Ascentage Pharma Group probability density function shows the probability of Ascentage Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Ascentage Pharma has a beta of 0.45. This suggests as returns on the market go up, Ascentage Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ascentage Pharma Group will be expected to be much smaller as well. Additionally Ascentage Pharma Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Ascentage Pharma Price Density   
       Price  

Predictive Modules for Ascentage Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ascentage Pharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
6.038.4810.93
Details
Intrinsic
Valuation
LowRealHigh
6.058.5010.95
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ascentage Pharma. Your research has to be compared to or analyzed against Ascentage Pharma's peers to derive any actionable benefits. When done correctly, Ascentage Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ascentage Pharma.

Ascentage Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ascentage Pharma is not an exception. The market had few large corrections towards the Ascentage Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ascentage Pharma Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ascentage Pharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.16
β
Beta against Dow Jones0.45
σ
Overall volatility
0.37
Ir
Information ratio -0.08

Ascentage Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ascentage Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ascentage Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ascentage Pharma generated a negative expected return over the last 90 days
Ascentage Pharma has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 27.91 M. Net Loss for the year was (782.42 M) with profit before overhead, payroll, taxes, and interest of 24.58 M.
Ascentage Pharma generates negative cash flow from operations
About 27.0% of the company shares are held by company insiders

Ascentage Pharma Fundamentals Growth

Ascentage Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ascentage Pharma, and Ascentage Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ascentage Pink Sheet performance.

About Ascentage Pharma Performance

By analyzing Ascentage Pharma's fundamental ratios, stakeholders can gain valuable insights into Ascentage Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ascentage Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ascentage Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about Ascentage Pharma performance evaluation

Checking the ongoing alerts about Ascentage Pharma for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ascentage Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ascentage Pharma generated a negative expected return over the last 90 days
Ascentage Pharma has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 27.91 M. Net Loss for the year was (782.42 M) with profit before overhead, payroll, taxes, and interest of 24.58 M.
Ascentage Pharma generates negative cash flow from operations
About 27.0% of the company shares are held by company insiders
Evaluating Ascentage Pharma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ascentage Pharma's pink sheet performance include:
  • Analyzing Ascentage Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ascentage Pharma's stock is overvalued or undervalued compared to its peers.
  • Examining Ascentage Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Ascentage Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ascentage Pharma's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Ascentage Pharma's pink sheet. These opinions can provide insight into Ascentage Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Ascentage Pharma's pink sheet performance is not an exact science, and many factors can impact Ascentage Pharma's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Ascentage Pink Sheet analysis

When running Ascentage Pharma's price analysis, check to measure Ascentage Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascentage Pharma is operating at the current time. Most of Ascentage Pharma's value examination focuses on studying past and present price action to predict the probability of Ascentage Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascentage Pharma's price. Additionally, you may evaluate how the addition of Ascentage Pharma to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated